U.S. Patent No. 12,471,776, titled "ANS Assessment Systems, Kits, and Methods," broadly covers systems, devices and methods for monitoring physiologic signals to assess autonomic nervous system (ANS) activity, including technologies designed to evaluate sympathetic and parasympathetic nervous system function through multiple physiologic assessment techniques. The patent also encompasses technologies that may support patient selection, procedural guidance, treatment feedback and post-treatment monitoring across a broad range of neuromodulation applications.